항오심제 시장 보고서(2025년)

Nausea medication is a drug designed to counteract the body's emetic response by targeting specific receptors in the brain or gastrointestinal tract that cause nausea and vomiting. It is used to reduce or prevent nausea and vomiting resulting from conditions such as motion sickness, anesthesia, chemotherapy, gastrointestinal disorders, or pregnancy-related issues.

The main types of nausea medications are antagonists, cannabinoids, and others. Antagonists are substances (typically drugs) that bind to receptors in the body to block or lessen a biological response by preventing the action of other substances, such as hormones or neurotransmitters. These medications are used for various conditions, including oncology, gastroesophageal reflux disease, motion sickness, seasickness, and more. They can be administered through different routes, such as oral, injectable, transdermal, and rectal. These medications are available at retail pharmacies, hospital pharmacies, online pharmacies, and other outlets, catering to various users, including hospitals, home care settings, ambulatory surgical centers, long-term care facilities, and individual consumers.

The nausea medicine market research report is one of a series of new reports from The Business Research Company that provides nausea medicine market statistics, including nausea medicine industry global market size, regional shares, competitors with a nausea medicine market share, detailed nausea medicine market segments, market trends and opportunities, and any further data you may need to thrive in the nausea medicine industry. This nausea medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The nausea medicine market size has grown strongly in recent years. It will grow from $3.02 billion in 2024 to $3.25 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth during the historic period can be attributed to the increase in chemotherapy cases, greater awareness of pregnancy-related nausea (NVP), growth in surgical procedures, increased recognition of motion sickness, higher prevalence of chronic gastrointestinal disorders, and the expansion of pediatric formulations.

The nausea medicine market size is expected to see strong growth in the next few years. It will grow to $4.31 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth during the forecast period can be linked to the rising adoption of cancer treatments, regulatory focus on safer ingredients, growth of telehealth and e-prescriptions, expansion of minimally invasive surgeries, and development of hospital infrastructure. Key trends in the forecast period include the integration of digital health solutions, development of targeted therapies, shift toward personalized medicine, adoption of transdermal patches for treatment, and advancements in drug formulations.

The increasing consumption of unhealthy diets is expected to drive the growth of the nausea medicine market in the future. Unhealthy diets typically involve high intake of processed foods, sugars, unhealthy fats, and salt while lacking essential nutrients such as vitamins, minerals, and fiber. The growing preference for processed and fast foods, which are more affordable and convenient than healthier alternatives, is fueling this trend. Consuming such diets often leads to gastrointestinal discomfort, acid reflux, indigestion, and nausea. Nausea medicines, such as antiemetics, help relieve these symptoms by addressing the underlying causes, including motion sickness, gastrointestinal issues, or medication side effects. These medicines work by blocking brain signals that trigger nausea or by soothing the stomach to reduce the urge to vomit. For example, the American Journal of Preventive Medicine reported in April 2025 that over 124,000 deaths in the United States annually are linked to ultra-processed foods. As unhealthy eating habits continue to rise, the demand for nausea medicine is also increasing.

Major companies in the nausea medicine market are focusing on developing innovative solutions, such as medications for chemotherapy-induced nausea. These drugs are specifically designed to prevent or alleviate nausea and vomiting caused by cancer chemotherapy, often by targeting serotonin or neurokinin receptors in the brain. For instance, in January 2023, Glenmark Pharmaceuticals, an India-based pharmaceutical company, launched AKYNZEO I.V., a ready-to-dilute intravenous injection that combines fosnetupitant and palonosetron to prevent chemotherapy-induced nausea and vomiting (CINV). This single-dose intravenous medication offers protection against both the acute and delayed phases of CINV, simplifying treatment and improving patient compliance by reducing the need for multiple antiemetic drugs.

In June 2022, Eagle Pharmaceuticals Inc., a US-based company specializing in injectable products, acquired Acacia Pharma Group plc for an undisclosed amount. The acquisition allows Eagle Pharmaceuticals to expand its acute care and oncology portfolio by adding two FDA-approved products, while also leveraging its experienced sales team to increase market uptake. Acacia Pharma Group, a UK-based pharmaceutical company, develops and commercializes various medicines, including anti-nausea treatments.

Major players in the nausea medicine market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bayer Aktiengesellschaft, Merck & Co. Inc., Sanofi S.A., Novartis AG, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Helsinn Healthcare SA, Mylan N.V., Viatris Inc., Baxter International Inc., Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Limited, Zydus Lifesciences Limited, Amneal Pharmaceuticals Inc.

North America was the largest region in the nausea medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in nausea medicine report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the nausea medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The nausea medicine market consists of sales of products including dopamine antagonists, ginger supplements, serotonin antagonists, anticholinergics, and antihistamines. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nausea Medicine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nausea medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nausea medicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The nausea medicine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Antagonists; Antagonists; Canabinoids; Other Types
• 2) By Indication: Oncology; Gastroesophageal Reflux Disease; Motion Sickness and Seasickness; Other Indications
• 3) By Route of Administration: Oral; Injectable; Transdermal; Rectal; Other Route of Administrations
• 4) By Distribution Channel: Retail Pharmacies; Hospital Pharmacies; Online Pharmacies; Other Distribution Channels
• 5) By End User: Hospitals; Homecare settings; Ambulatory Surgical centres; Long-term Care Facilities; Individual Consumers
• Subsegments:
• 1) By Antagonists: Serotonin Antagonists; Neurokinin-1 (NK1) Receptor Antagonists; Dopamine Antagonists
• 2) By Antihistamines: H1 Antihistamines; H2 Antihistamines
• 3) By Cannabinoids: THC (Tetrahydrocannabinol); CBD (Cannabidiol)
• 4) By Other Types: Corticosteroids; Benzodiazepines; Ginger-Based Medications
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; AbbVie Inc.; Bayer Aktiengesellschaft; Merck & Co. Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Nausea Medicine Market Characteristics

3. Nausea Medicine Market Trends And Strategies

4. Nausea Medicine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Nausea Medicine Growth Analysis And Strategic Analysis Framework

• 5.1. Global Nausea Medicine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Nausea Medicine Market Growth Rate Analysis
• 5.4. Global Nausea Medicine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Nausea Medicine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Nausea Medicine Total Addressable Market (TAM)

6. Nausea Medicine Market Segmentation

• 6.1. Global Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antagonists
• Antihistamines
• Canabinoids
• Other Types
• 6.2. Global Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Gastroesophageal Reflux Disease
• Motion Sickness and Seasickness
• Other Indications
• 6.3. Global Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Injectable
• Transdermal
• Rectal
• Other Route of Administrations
• 6.4. Global Nausea Medicine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies
• Other Distribution Channels
• 6.5. Global Nausea Medicine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare settings
• Ambulatory Surgical centres
• Long-term Care Facilities
• Individual Consumers
• 6.6. Global Nausea Medicine Market, Sub-Segmentation Of Antagonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Serotonin Antagonists
• Neurokinin-1 (NK1) Receptor Antagonists
• Dopamine Antagonists
• 6.7. Global Nausea Medicine Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• H1 Antihistamines
• H2 Antihistamines
• 6.8. Global Nausea Medicine Market, Sub-Segmentation Of Canabinoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• THC (Tetrahydrocannabinol)
• CBD (Cannabidiol)
• 6.9. Global Nausea Medicine Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Corticosteroids
• Benzodiazepines
• Ginger-Based Medications

7. Nausea Medicine Market Regional And Country Analysis

• 7.1. Global Nausea Medicine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Nausea Medicine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Nausea Medicine Market

• 8.1. Asia-Pacific Nausea Medicine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Nausea Medicine Market

• 9.1. China Nausea Medicine Market Overview
• 9.2. China Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Nausea Medicine Market

• 10.1. India Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Nausea Medicine Market

• 11.1. Japan Nausea Medicine Market Overview
• 11.2. Japan Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Nausea Medicine Market

• 12.1. Australia Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Nausea Medicine Market

• 13.1. Indonesia Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Nausea Medicine Market

• 14.1. South Korea Nausea Medicine Market Overview
• 14.2. South Korea Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Nausea Medicine Market

• 15.1. Western Europe Nausea Medicine Market Overview
• 15.2. Western Europe Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Nausea Medicine Market

• 16.1. UK Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Nausea Medicine Market

• 17.1. Germany Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Nausea Medicine Market

• 18.1. France Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Nausea Medicine Market

• 19.1. Italy Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Nausea Medicine Market

• 20.1. Spain Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Nausea Medicine Market

• 21.1. Eastern Europe Nausea Medicine Market Overview
• 21.2. Eastern Europe Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Nausea Medicine Market

• 22.1. Russia Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Nausea Medicine Market

• 23.1. North America Nausea Medicine Market Overview
• 23.2. North America Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Nausea Medicine Market

• 24.1. USA Nausea Medicine Market Overview
• 24.2. USA Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Nausea Medicine Market

• 25.1. Canada Nausea Medicine Market Overview
• 25.2. Canada Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Nausea Medicine Market

• 26.1. South America Nausea Medicine Market Overview
• 26.2. South America Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Nausea Medicine Market

• 27.1. Brazil Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Nausea Medicine Market

• 28.1. Middle East Nausea Medicine Market Overview
• 28.2. Middle East Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Nausea Medicine Market

• 29.1. Africa Nausea Medicine Market Overview
• 29.2. Africa Nausea Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Nausea Medicine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Nausea Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Nausea Medicine Market Competitive Landscape And Company Profiles

• 30.1. Nausea Medicine Market Competitive Landscape
• 30.2. Nausea Medicine Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer Aktiengesellschaft Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Nausea Medicine Market Other Major And Innovative Companies

• 31.1. Sanofi S.A.
• 31.2. Novartis AG
• 31.3. AstraZeneca PLC
• 31.4. Abbott Laboratories
• 31.5. GlaxoSmithKline plc
• 31.6. Takeda Pharmaceutical Company Limited
• 31.7. Eli Lilly and Company
• 31.8. Helsinn Healthcare SA
• 31.9. Mylan N.V.
• 31.10. Viatris Inc.
• 31.11. Baxter International Inc.
• 31.12. Teva Pharmaceutical Industries Limited
• 31.13. Sun Pharmaceutical Industries Limited
• 31.14. Zydus Lifesciences Limited
• 31.15. Amneal Pharmaceuticals Inc.

32. Global Nausea Medicine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Nausea Medicine Market

34. Recent Developments In The Nausea Medicine Market

35. Nausea Medicine Market High Potential Countries, Segments and Strategies

• 35.1 Nausea Medicine Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Nausea Medicine Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Nausea Medicine Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer